Effects of the gaba-uptake inhibitor tiagabine in rat globus pallidus

Experimental Brain Research

Volumn 152, Issue 2, 2003, Pages 263-269

  Chen, Lei ^a,b   Yung, Wing Ho ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

CGP55845; Globus pallidus; IPSC; Tiagabine

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; CARRIER PROTEIN; PRESYNAPTIC RECEPTOR; TIAGABINE; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ACTION POTENTIAL; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; CONTROLLED STUDY; EPILEPSY; GLOBUS PALLIDUS; MALE; NONHUMAN; PATCH CLAMP; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; ELECTRIC CONDUCTIVITY; GABA ANTAGONISTS; GLOBUS PALLIDUS; NEURAL INHIBITION; NEUROTRANSMITTER UPTAKE INHIBITORS; NIPECOTIC ACIDS; PHOSPHINIC ACIDS; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SYNAPSES;

EID: 0141788196     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-003-1549-7     Document Type: Article

References (36)

1. Aiko Y, Hosokawa S, Shima F, Kato M, Kitamura K (1988) Alterations in local cerebral glucose utilization during electrical stimulation of the striatum and globus pallidus in rats. Brain Res 442:43-52
2. André V, Pineau N, Motte J, Marescauz C, Nehlig A (1998) Mapping of neuronal networks underlying generalized seizures induced by increasing doses of pentylenetetrazole in the immature and adult rat: a c-fos immunohistochemical study. Eur J Neurosci 10:2094-2106
3. Bolam P, Hanley JJ, Booth PAC, Bevan MD (2000) Synaptic organization of the basal ganglia. J Anat 196:527-542
4. Borden LA (1996) GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem Int 29:335-356
5. Borden LA, Dhar TGM, Smith KE, Weinshank RL, Branchek TA, Gluchowski C (1994) Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol 269:219-224
6. Chan PKY, Yung WH (1999) Inhibitory postsynaptic currents of rat substantia nigra pars reticulata neurons: role of GABA receptors and GABA uptake. Brain Res 838:18-26
7. B receptors in the basal ganglia in monkeys. Neuroscience 95:127-140
8. B receptor activation in rat globus pallidus. Neuroscience 114:417-425
9. Cooper AJ, Stanford IM (2000) Electrophysiological and morphological characteristics of three subtypes of rat globus pallidus neurone in vitro. J Physiol (Lond) 527:291-304
10. Crawford P, Meinardi H, Brown S, Rentmeester TW, Pedersen B, Pedersen PC, Lassen LC (2001) Tiagabine: efficacy and safety in adjunctive treatment of partial seizures. Epilepsia 42:531-538
11. Dalby NO (2000) GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors. Neuropharmacology 39:2399-2407
12. Dalby NO, Nielsen EB (1997) Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res 28:63-72
13. Depaulis A, Vergnes M, Marescaux C (1993) Endogenous control of epilepsy: the nigral inhibitory system. Prog Neurobiol 42:33-52
14. Deransart C, Riban V, Lê B-T, Hechler V, Marescauz C, Depaulis A (1999) Evidence for the involvement of the pallidum in the modulation of seizures in a genetic model of absence epilepsy in the rat. Neurosci Lett 265:131-134
15. Fink-Jensen A, Suzdak PD, Swedberg MDB, Judge ME, Hansen L, Nielsen PG (1992) The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur J Pharmacol 220:197-201
16. Gale K (1989) GABA in epilepsy: the pharmacological basis. Epilepsia (Suppl 3) 30:1-11
17. Genton P, Guerrini R, Perucca E (2001) Tiagabine in clinical practice. Epilepsia (Suppl 3) 42:42-45
18. Haugvicova R, Skutova M, Kubova H, Suchomelova L, Mares P (2000) Two different anticonvulsant actions of tiagabine in developing rats. Epilepsia 41:1375-1381
19. Iadarola MJ, Gale K (1982) Substantia nigra: site of anti-convulsant activity mediated by gamma-aminobutyric acid. Science 218:1237-1240
20. Ikegaki N, Saito N, Hashima M, Tanaka C (1994) Production of specific antibodies against GABA transporter subtypes (GAT1, GAT2, GAT3) and their application to immunohistochemistry. Mol Brain Res 26:47-54
21. Jackson MF, Esplin B, Capek R (1999) Activity-dependent enhancement of hyperpolarizing and depolarizing gamma-aminobutyric acid (GABA) synaptic responses following inhibition of GABA uptake by tiagabine. Epilepsy Res 37: 25-36
22. Nambu A, Llinas R (1994) Electrophysiology of globus pallidus neurons in vitro. J Neurophysiol 72:1127-1139
23. Nielsen EB, Suzdak PD, Andersen KE, Knutsen LJS, Sonnewald U, Braestrup C (1991) Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. Eur J Pharmacol 196:257-266
24. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, New York
25. Radian R, Ottersen OP, Castel M, Kanner B (1990) Immunocyto-chemical localization of the GABA transporter in rat brain. J Neurosci 10:1319-1330
26. Roepstroff A, Lamvert JDC (1994) Factors contributing to the decay of the stimulus-evoked IPSCs in rat hippocampal CA1 neurons. J Neurophysiol 72:2911-2926
27. Sabau A, Frahm C, Pfeiffer M, Breustedt J-M, Piechotta A, Numberger M, Engel D, Heinemann U, Draguhn A (1999) Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro. Eur J Pharmacol 383:259-266
28. Saňudo-Peňa MC, Walker JM (1997) Role of the subthalamic nucleus on cannabinoid actions in the substantia nigra of the rat. J Neurophysiol 77:1635-1638
29. Saňudo-Peňa MC, Walker JM (1998) Effect of intrapallidal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Synapse 28:27-32
30. Schachter SC (2001) Pharmacology and clinical experience with tiagabine. Expert Opin Pharmacother 2:179-187
31. Smith SE, Parvez NS, Chapman AG, Meldrum BS (1995) The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anti-convulsant in two animal models of reflex epilepsy. Eur J Pharmacol 273:259-265
32. 3H]tiagabine (NNC 05-328) to the GABA uptake carrier. Brain Res 647:231-241
33. Thompson SM, Gähwiler BH (1992) Effects of the GABA uptake inhibitor tiagabine on inhibitory synaptic potentials in rat hippocampal slice cultures. J Neurophysiol 67:1698-1701
34. B receptor antagonists on absences and convulsive seizures. Eur J Pharmacol 332:245-255
35. Yamaguchi K, Nabeshima T, Kameyama T (1986) Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior. J Pharmacobiodyn 9:975-986
36. 67) mRNA localization. Mol Brain Res 44:205-218